Dashboard
Dividend Tracker
My Portfolio
Portfolios
Investors
Analysts
Community
Calendars
Economic Calendar
Dividend Calendar
Earnings Calendar
Splits Calendar
IPO Calendar
Markets
Stocks
Indices
Forex
Crypto
Commodities
News
Sign Up
Sign In
Your search results will appear here.
Light Mode
Dark Mode
Sign Up
Sign In
UnitedHealth Group Incorporated (0R0O)
Market Closed
17 Jul, 15:30
LSE
All
(17)
DE
(6)
AT
(1)
CH
(1)
PE
(1)
CL
(2)
MX
(1)
IT
(2)
GB
(2)
US
(1)
NYSE
Primary
LSE
XMIL
XETRA
XSGO
XDUS
XSTU
BVL
XMEX
XHAN
XWBO
XFRA
XMUN
XSGO
XMIL
CBOE
SIX
$
435.
37
+6.7
+1.563%
$
363.45B
Market Cap
23.04
P/E Ratio
0.16%
Div Yield
13,984
Volume
22.88
Eps
$
428.67
Previous Close
Watching
Watch
Add Transaction
Day Range
423
437.53
Year Range
236.93
461
Want to track
0R0O
and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Get Started For Free
Overview
Dividends
Earnings
Splits
Statistics
News
Historical Data
UnitedHealth Group Incorporated (0R0O) Statistics
Valuation metrics
Market Cap
363.45B
Enterprise value
517.8B
Trailing P/E (ttm)
13.53
Forward P/E
-
PEG ratio
163.74
Price/Sales (ttm)
0.78
Price/Book (mrq)
3.16
Enterprise Value/Revenue
1.44
Enterprise Value/EBITDA
14.99
Overview
Shares outstanding
907.68M
Float
932.46M
Shares short
-
% Held by insiders
0%
% Held by institutions
0.89%
Average volume (10 days)
7.57K
Average volume (90 days)
12.67K
Price summary
52-Week low
236.93
52-Week high
461
Beta
0.65
50-Day moving average
323.93
200-Day moving average
322.58
Dividends and splits
Forward annual dividend rate
8.84
Forward annual dividend yield
0.0225%
Trailing annual dividend rate
8.84
Trailing annual dividend yield
0.0225%
5-Year annual dividend yield
1.36%
Payout ratio
0.31
Dividend Date
23 Jun 2026
Ex-Dividend Date
15 Jun 2026
Last split factor
2:1
Last split Date
31 May 2005
Financials
Fiscal year
Fiscal year ends
31 Dec 2022
Most recent quarter (mrq)
31 Mar 2026
Profitability
Profit margin
0.06%
Operating margin
0.09%
Operational effectiveness
Return on assets
0.08%
Return on equity
0.25%
Income Statement
Revenue (ttm)
359.98B
Revenue per share (ttm)
387.6
Quarterly revenue growth (yoy)
0.14%
Gross profit (ttm)
89.84B
EBITDA
23.16B
Net income to common (ttm)
21.69B
Diluted EPS (ttm)
22.33
Quarterly earnings growth (yoy)
0.11%
Balance Sheet
Total cash (mrq)
44.1B
Total cash per share (mrq)
47.11
Total debt (mrq)
63.37B
Total Debt/Equity (mrq)
67.43
Current ratio (mrq)
0.81%
Book value per share (mrq)
95.69
Cash Flow
Cash flow statement
29.73B
Levered free cash flow (LFCF)
23.03B